Recently Viewed
empty-cart

There are no Recent Items

Close
Login/Register

Close
Single User License Price USD 2500
Single User License Price INR 175000
Corporate User License Price USD 3200
Corporate User License Price INR 224000
Request a Quote

Report Title

North America Wound Care Biologics Market_Companies Profiles, Size, Share, Growth, Trends and Forecast to 2025

Quote Request for License Type
License Type Price  
Single User License USD 2500
Enterprise Wide License USD 3200
"Thanks for submitting the form. Our marketing team will connect back to you for the budget constraint."
Close
REQUEST A CUSTOMIZED RESEARCH

Report Title

North America Wound Care Biologics Market_Companies Profiles, Size, Share, Growth, Trends and Forecast to 2025


Quote Request for License Type
License Type Price  
Single User License USD 2500
"Thanks for letting us know your requirement. Our research team will connect back to you for the bespoke requirement."
Close
REQUEST FOR SAMPLE REPORT

Report Title

North America Wound Care Biologics Market_Companies Profiles, Size, Share, Growth, Trends and Forecast to 2025

"Thanks for submitting the form. The concerned team will send the sample report in the next 12 hours."
"Thank you for downloading the sample report."
Close

North America Wound Care Biologics Market_Companies Profiles, Size, Share, Growth, Trends and Forecast to 2025



Executive Summary

North America wound care biologics market is expected to grow with a healthy CAGR in the forecast period 2018 to 2025. The new market report contains data for historic year 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.

Prominent factors driving the growth of this market consist of increasing incidence of foot ulcers, increasing incidence of burn cases, rising number of geriatric population, innovation in wound care biologics are fuel the growth of wound care biologics market.

The key market players for North America wound care biologics market are listed below:

Integra LifeSciences

ConvaTec Inc.

AlloSource

Amniox Medical, Inc.

Marine Polymer Technologies, Inc.

Solsys Medical

ACell Inc.

Kerecis

WRIGHT MEDICAL GROUP N.V.

Vericel Corporation

Anika Therapeutics, Inc.

Skye Biologics Inc.

BioHorizons IPH, Inc

Alphatec Spine, Inc.

Amnio Technology, LLC

Molnlycke Health Care AB

Smith and Nephew

MiMedx

Organogenesis Inc.

Osiris Therapeutics, Inc.

The North America wound care biologics market is segmented into:

Product Type

Wound Type

End User

On the basis of product type the North America wound care biologics market is segmented into synthetic skin grafts segment, growth factors segment, allografts segment, xenografts segment. In 2018, synthetic skin grafts segment is expected to dominate the North America wound care biologics market with highest market shares. However, allografts segment is expected to grow at the highest CAGR in the forecast period. Growth factors segment is further sub segmented into platelet-derived growth factor (PDGF) segment, platelet rich plasma (PRP) segment, epidermal growth factor (EGF) segment and basic fibroblast growth factor (BFGF) segment, granulocyte colony stimulating factor (G-CSF), talactoferrin alfa segment, thrombin peptide (TP508) segment, keratinocyte growth factor (KGF) segment.

On the basis of wound type the North America wound care biologics market is categorized into wounds, and ulcers, burns. In 2018, wounds segment is expected to dominate the North America wound care biologics market with the highest market shares. However, ulcers segment is expected to grow at the highest CAGR in the forecast period.

On the basis of end user North America wound care biologics market is segmented into hospitals, wound care centres and ambulatory centres, clinics, community healthcare centers. In 2018, hospitals are expected to dominate the North America wound care biologics market with the highest CAGR in the forecast period 2018 to 2025.

Based on geography, the market is segmented into 3 geographical regions:

U.S.

Canada

Mexico

Covered in this report

The report covers the present scenario and the growth prospects of the North America wound care biologics market for 2018-2025. To calculate the market size, the report considers the revenue generated from the sales of the web conferencing and unified communication and collaboration (UC&C) and video conferencing, secondary resources and doing in-depth company share analysis of major 10 players in the market.

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Table Of Contents

1 Introduction 30

1.1 Objectives Of The Study 30

1.2 Market Definition 30

1.3 Overview Of North America Wound Care Biologics Market 30

1.4 Currency And Pricing 31

1.5 Limitation 31

1.6 Markets Covered 32

2 Market Segmentation 34

2.1 Markets Covered 34

2.2 Geographic Scope 35

2.3 Years Considered For The Study 36

2.4 Currency And Pricing 36

2.5 Research Methodology 37

2.6 Primary Interviews With Key Opinion Leaders 40

2.1 Dbmr Market Position Grid 41

2.2 Dbmr Market Challenge Matrix 42

2.3 Secondary Sources 43

2.4 Assumptions 43

3 Market Overview 44

3.1 Drivers 46

3.1.1 Increasing Cases Of Diabetic Foot Ulcers 46

3.1.2 Increasing Incidences Of Burn Cases 46

3.1.3 Rising Number Of Geriatric Population 47

3.1.4 Innovation In Wound Care Biologics 48

3.1.5 New Product Launches 50

3.2 Restrains 50

3.2.1 High Cost Of Wound Treatment And Wound Care Biologics 50

3.2.2 Risk Of Skin Substitue Failure 51

3.3 Opportunities 52

3.3.1 3D Skin Printing 52

3.3.2 Awareness Programs 53

3.4 Challenges 54

3.4.1 Lack Of Wound Management Services 54

4 Executive Summary 55

5 Premium Insights 58

6 North America Wound Care Biologics Market, By Product Type 63

6.1 Overview 64

6.2 Synthetic Skin Grafts 66

6.3 Growth Factors 67

6.3.1 Platelet Derived Growth Factor (Pdgf) 70

6.3.2 Platelet Rich Plasma (Prp) 70

6.3.3 Epidermal Growth Factors (Egf) 70

6.3.4 Basic Fibroblast Growth Factors (Bfgf) 71

6.3.5 Granulocyte Colony Stimulating Factor (G-Csf) 71

6.3.6 Talactoferrin Alfa 71

6.3.7 Thrombin Peptide 72

6.3.8 Keratinocy Growth Factor (Kgf) 72

6.4 Allografts 73

6.5 Xenografts 74

7 North America Wound Care Biologics Market, By Wound Type 76

7.1 Overview 77

7.2 Wounds 78

7.2.1 Surgical Wound 80

7.2.1.1 Skin Surgery 81

7.2.1.1.1 Wound Closure 82

7.2.1.1.2 Skin Biopsy 82

7.2.1.1.3 Skin Flap 82

7.2.1.1.4 Skin Graft 82

7.2.1.1.5 Others 82

7.2.1.2 Cosmetic Procedure 83

7.2.1.2.1 Brest Enhancement 84

7.2.1.2.2 Facial Contouring 85

7.2.1.2.3 Facial Rejuvenation: 85

7.2.1.2.4 Body Contouring 85

7.2.1.2.5 Skin Rejuvenation 85

7.2.1.2.6 Others 86

7.2.1.3 Gynecologic Procedures 86

7.2.1.3.1 Pubovaginalis Sling 86

7.2.1.3.2 Pelvic Floor Reconstruction 87

7.2.1.3.3 Rectocele Repair Surgery 87

7.2.1.3.4 Others 87

7.2.1.4 Gastrointestinal Procedure 87

7.2.1.4.1 General Gastrointestinal Surgery 88

7.2.1.4.2 Hernia 89

7.2.1.4.3 Others 89

7.2.2 Acute Wounds 90

7.2.3 Chronic Wounds 90

7.2.4 Traumatic Wounds 91

7.3 Burns 91

7.3.1 Ulcers 92

7.3.2 Diabetic Ulcers 94

7.3.3 Pressure Ulcer 94

7.3.4 Venous Ulcer 95

7.3.5 Others 95

8 North America Wound Care Biologics Market, By End User 96

8.1 Overview 97

8.2 Hospitals 99

8.3 Wound Care Centers 100

8.4 Ambulatory Surgical Centers 101

8.5 Clinics 103

8.6 Community Healthcare Center 104

9 North America Wound Care Biologics Market: Geography 105

9.1 North America 105

9.1.1 U.S. 116

9.1.2 Canada 123

9.1.3 Mexico 130

10 North America Wound Care Biologics Market, Company Landscape 137

10.1 Company Share Analysis: North America 137

11 Company Profile 138

11.1 Mimedx. 138

11.1.1 Company Overview 138

11.1.2 Revenue Analysis: 138

11.1.3 Company Share Analysis: 139

11.1.4 Product Portfolio 139

11.1.5 Recent Developments 140

11.2 Organogenesis Inc 141

11.2.1 Company Overview 141

11.2.2 Geographic Presence 141

11.2.3 Company Share Analysis: 142

11.2.4 Product Portfolio 142

11.2.5 Recent Developments 143

11.3 Integra Lifesciences 144

11.3.1 Company Overview 144

11.3.2 Revenue Analysis 144

11.3.3 Company Share Analysis: 145

11.3.4 Product Portfolio 145

11.3.5 Recent Developments 146

11.4 Convatec Inc. 147

11.4.1 Company Overview 147

11.4.2 Revenue Analysis 147

11.4.3 Company Share Analysis: 148

11.4.4 Product Portfolio : 148

11.4.5 Recent Developments 148

11.5 Acell Inc. 149

11.5.1 Company Overview 149

11.5.2 Product Portfolio 149

11.5.3 Recent Developments 150

11.6 Allosource 151

11.6.1 Company Overview 151

11.6.2 Product Portfolio 151

11.6.3 Recent Developments 152

11.7 Alphatec Spine, Inc. ( A Subsidary Of Alphatec Holdings, Inc) 153

11.7.1 Company Overview 153

11.7.2 Product Portfolio 153

11.7.3 Recent Developments 153

11.8 Amnio Technology, Llc 154

11.8.1 Company Overview 154

11.8.2 Product Portfolio 154

11.8.3 Recent Developments 155

11.9 Amniox Medical, Inc. 156

11.9.1 Company Overview 156

11.9.2 Product Portfolio 156

11.9.3 Recent Developments 157

11.10 Anika Therapeutics, Inc. 158

11.10.1 Company Overview 158

11.10.2 Revenue Analysis 158

11.10.3 Product Portfolio 159

11.10.4 Recent Developments 159

11.11 Biohorizons Iph, Inc ( A Subsidary Of Henry Schein, Inc.) 160

11.11.1 Company Overview 160

11.11.2 Geographicpresence 160

11.11.3 Product Portfolio 161

11.11.4 Recent Developments 161

11.12 Kerecis 162

11.12.1 Company Overview 162

11.12.2 Geographical Presence 162

11.12.3 Product Portfolio 163

11.12.4 Recent Developments 163

11.13 Marine Polymer Technologies, Inc 164

11.13.1 Company Overview 164

11.13.2 Product Portfolio 164

11.13.3 Recent Developments 164

11.14 Molnlycke Health Care Ab 165

11.14.1 Company Overview 165

11.14.2 Revenue Analysis 165

11.14.3 Product Portfolio 166

11.14.4 Recent Developments 166

11.15 Osiris Therapeutics, Inc. 167

11.15.1 Company Overview 167

11.15.2 Revenue Analysis 167

11.15.3 Product Portfolio 168

11.15.4 Recent Developments 168

11.16 Skye Biologics Inc. 169

11.16.1 Company Overview 169

11.16.2 Product Portfolio : 169

11.16.3 Recent Development: 170

11.17 Smith And Nephew 171

11.17.1 Company Overview 171

11.17.2 Revenue Analysis 171

11.17.3 Product Portfolio 172

11.17.4 Recent Developments 172

11.18 Solsys Medical. 173

11.18.1 Company Overview 173

11.18.2 Product Portfolio 174

11.18.3 Recent Developments 174

11.19 Vericel Corporation. 175

11.19.1 Company Overview 175

11.19.2 1.1.2 Revenue Analysis 175

11.19.3 Product Portfolio 176

11.19.4 Recent Developments 176

11.20 Wright Medical Group N.V 177

11.20.1 Company Overview 177

11.20.2 1.1.2 Revenue Analysis 177

11.20.3 Product Portfolio 178

11.20.4 Recent Developments 179

12 Related Reports 180

To know more information on Purchase by Section, please send a mail to sales@kenresearch.com

List Of Figures

Figure 1 North America Wound Care Biologics Market: Segmentation 20

Figure 2 North America Wound Care Biologics Market: Data Triangulation 23

Figure 3 North America Wound Care Biologics Market: Research Snapshot 24

Figure 4 North America Wound Care Biologics Market: Bottom Up Approach 25

Figure 5 North America Wound Care Biologics Market: Top Down Approach 25

Figure 6 North America Wound Care Biologics Market: Interview Demographics 26

Figure 1 North America Wound Care Biologics Market: Dbmr Market Position Grid 27

Figure 2 North America Wound Care Biologics Market: The Market Challenge Matrix 28

Figure 3 Drivers, Restraints, Opportunities And Challenges Of North America Wound Care Biologics Market 31

Figure 4 Aging Population In Different Countries (2014, 2017 & 2020) 34

Figure 5 North America Wound Care Biologics Market: Segmentation 43

Figure 6 Increasing Prevelance Of Diabetic Foot Ulcers And Increasing Incidences Of Burn Cases Are Expected To Drive The Market For North America Wound Care Biologics In The Forecast Period 2018 To 2025 44

Figure 7 Synthetic Skin Grafts In North America Wound Care Biologics Is Expected To Account For The Largest Share Of The North America Wound Care Biologics Market In 2018 & 2025 45

Figure 8 Asia Pacific Is The Maximum Growing And Most Profitable Revenue Pockets For North America Wound Care Biologics Market In The Forecast Period From 2018 To 2025 46

Figure 9 Worldwide Prevalence Of Various Wound Types, 2011 47

Figure 10 Cases Of Burn Injuries, (2009-2012) 47

Figure 11 Prevalence Of Pressure Ulcers In Few Countries 48

Figure 12 Number Of Surgical Procedures And Surgical Site Infections 48

Figure 13 North America Wound Care Biologics Market: By Product Type, 2017 50

Figure 14 North America Wound Care Biologics Market: By Wound Type, 2017 63

Figure 15 North America Wound Care Biologics Market: By End User, Snapshot 2017 83

Figure 16 North America Wound Care Biologics Market: Snapshot (2017) 91

Figure 17 North America Wound Care Biologics Market: By Country (2017) 92

Figure 18 North America Wound Care Biologics Market: By Country (2018 & 2025) 92

Figure 19 North America Wound Care Biologics Market, By Country (2017 & 2025) 93

Figure 20 North America Wound Care Biologics Market, By Product Type (2018 -2025) 94

Figure 21 North America Wound Care Biologics Market: Company Share 2017 (%) 123

List Of Tables

Table 1 North America Wound Care Biologics Market, By Product Type, 2016- 2025 (Usd Million) 52

Table 2 North America Synthetic Skin Grafts In Wound Care Biologics Market, By Region, 2016- 2025 (Usd Million) 53

Table 3 North America Growth Factors In Wound Care Biologics Market, By Product Type, 2016- 2025 (Usd Million) 55

Table 4 North America Growth Factors In Wound Care Biologics Market, By Region, 2016- 2025 (Usd Million) 56

Table 5 North America Allografts In Wound Care Biologics Market, By Region, 2016- 2025 (Usd Million) 60

Table 6 North America Xenografts In Wound Care Biologics Market, By Region, 2016- 2025 (Usd Million) 62

Table 7 North America Wound Care Biologics Market, By Wound Type, 2015- 2025 (Usd Million) 65

Table 8 North America Wounds In Wound Care Biologics Market, By Region, 2016- 2025 (Usd Million) 66

Table 9 North America Wounds In Wound Care Biologics Market, By Wound Type, 2016- 2025 (Usd Million) 66

Table 10 North America Surgical Wound In Wound Care Biologics Market, 2016-2025 (Usd Million) 67

Table 11 North America Skin Surgery In Wound Care Biologics Market, 2016-2025 (Usd Million) 68

Table 12 Number Of Cosmetic Surgery, 2016 & 2017 70

Table 13 North America Cosmetic Surgery In Wound Care Biologics Market, By Wound Type, 2016-2025 (Usd Million) 71

Table 14 North America Gynecologic Procedures In Wound Care Biologics Market, By Wound Type, 2016-2025 (Usd Million) 73

Table 15 North America Gastrointestinal Procedures In Wound Care Biologics Market, By Wound Type 2018-2025 (Usd Million) 75

Table 16 North America Burns In Wound Care Biologics Market, By Region, 2016- 2025 (Usd Million) 79

Table 17 North America Ulcers In Wound Care Biologics Market, By Region, 2016- 2025 (Usd Million) 80

Table 18 North America Ulcers In Wound Care Biologics Market, By Wound Type 2016-2025 (Usd Million) 80

Table 19 North America Wound Care Biologics Market, By End User, 2016-2025 (Usd Million) 85

Table 20 North America Hospitals In Wound Care Biologics Market, By Region, 2016- 2025 (Usd Million) 86

Table 21 North America Wound Care Center In Wound Care Biologics Market, By Region, 2016- 2025 (Usd Million) 87

Table 22 Statistics For Ambulatory Surgical Center. U.S. 88

Table 23 North America Ambulatory Surgical Centers In Wound Care Biologics Market, By Region, 2016- 2025 (Usd Million) 89

Table 24 North America Clinics In Wound Care Biologics Market, By Region, 2016- 2025 (Usd Million) 90

Table 25 North America Community Healthcare Center In Wound Care Biologics Market, By Region, 2016- 2025 (Usd Million) 91

Table 26 North America Wound Care Biologics Market, By Country, 2016-2025 (Usd Million ) 96

Table 27 North America Wound Care Biologics, By Product Type, 2016-2025, (Usd Million) 96

Table 28 North America Growth Factors In Wound Care Biologics, By Product Type, 2016-2025, (Usd Million) 97

Table 29 North America Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 97

Table 30 North America Wounds In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 98

Table 31 North America Surgical Wounds In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 98

Table 32 North America Skin Surgery In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 99

Table 33 North America Cosmetic Procedures In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 100

Table 34 North America Gynecologic Procedures In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 100

Table 35 North America Gynecologic Procedures In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 101

Table 36 North America Ulcers In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 101

Table 37 North America Wound Care Biologics, By End User, 2016-2025, (Usd Million) 102

Table 38 U.S. Wound Care Biologics, By Product Type, 2016-2025, (Usd Million) 103

Table 39 U.S. Growth Factors In Wound Care Biologics, By Product Type, 2016-2025, (Usd Million) 104

Table 40 U.S. Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 104

Table 41 U.S. Wounds In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 105

Table 42 U.S. Surgical Wounds In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 105

Table 43 U.S. Skin Surgery In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 106

Table 44 U.S. Cosmetic Procedures In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 107

Table 45 U.S. Gynecologic Procedures In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 107

Table 46 U.S. Gynecologic Procedures In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 108

Table 47 U.S. Ulcers In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 108

Table 48 U.S. Wound Care Biologics, By End User, 2016-2025, (Usd Million) 109

Table 49 Canada Wound Care Biologics, By Product Type, 2016-2025, (Usd Million) 110

Table 50 Canada Growth Factors In Wound Care Biologics, By Product Type, 2016-2025, (Usd Million) 111

Table 51 Canada Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 111

Table 52 Canada Wounds In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 112

Table 53 Canada Surgical Wounds In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 112

Table 54 Canada Skin Surgery In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 113

Table 55 Canada Cosmetic Procedures In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 114

Table 56 Canada Gynecologic Procedures In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 114

Table 57 Canada Gynecologic Procedures In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 115

Table 58 Canada Ulcers In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 115

Table 59 Canada Wound Care Biologics, By End User, 2016-2025, (Usd Million) 116

Table 60 Mexico Wound Care Biologics, By Product Type, 2016-2025, (Usd Million) 117

Table 61 Mexico Growth Factors In Wound Care Biologics, By Product Type, 2016-2025, (Usd Million) 118

Table 62 Mexico Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 118

Table 63 Mexico Wounds In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 119

Table 64 Mexico Surgical Wounds In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 119

Table 65 Mexico Skin Surgery In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 120

Table 66 Mexico Cosmetic Procedures In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 121

Table 67 Mexico Gynecologic Procedures In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 121

Table 68 Mexico Gynecologic Procedures In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 122

Table 69 Mexico Ulcers In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 122

Table 70 Mexico Wound Care Biologics, By End User, 2016-2025, (Usd Million) 123

MiMedx

Organogenesis Inc.

Integra LifeSciences

ConvaTec Inc.

Smith and Nephew

INTEGRA LIFE SCIENCES CORPORATION

Molnlycke Health Care AB


Related Products in vertical
red-whiteline

RECENT VIEWED REPORTS



Sign up for newsletter

Close
Apply For Job

  • Applicant Name
  • Job Function
  • Total Experience
  • Skills
  • Email ID
  • Notice Period
  • Current CTC & Expected CTC
  • Phone Number
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Your resume has been successfully received. HR will connect you within 14 days in case your resume gets shortlisted."
Close
Download Company Brochure

  • Name
  • Email
  • Company Name
  • Select Country*
  • Phone Number
  • Validation
  •   info-icon

    If validation code does not match, please refresh the page.

Close
Engage With Us

  • Name
  • Designation
  • Email
  • Phone No.
  • Company Name
  • Company URL
  • Select Country*
  • Requirements/ Comments
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Thanks for submitting the form. The concerned team will respond to your query in the next 8-12 hours"
Close

Compare

Expand

person